Aquestive Therapeutics, Inc. AQST Operating Lease Liability - Undiscounted Excess Amount
Operating Lease Liability - Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount?
- Aquestive Therapeutics, Inc. (AQST) reported operating lease liability - undiscounted excess amount of $2.61M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount changed year-over-year?
- Aquestive Therapeutics, Inc.'s operating lease liability - undiscounted excess amount decreased by 22.4% year-over-year, from $3.36M to $2.61M.
- What does operating lease liability - undiscounted excess amount mean?
- This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.